Skip to main content
Erschienen in: International Journal of Hematology 2/2009

01.03.2009 | Original Article

Cytogenetic analysis in childhood acute lymphoblastic leukemia: experience at a single institution in Korea

verfasst von: Young Joo Kwon, Jae Wook Lee, Myung Shin Kim, Pil Sang Jang, Nak Gyun Chung, Dae Chul Jeong, Yong Goo Kim, Kyung Ja Han, Soon Ju Lee, Bin Cho, Hack Ki Kim

Erschienen in: International Journal of Hematology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

We evaluated major cytogenetic abnormalities associated with childhood acute lymphoblastic leukemia (ALL) through both fluorescent in situ hybridization and conventional chromosomal analysis for 132 ALL patients diagnosed at St Mary’s Hospital in Korea. Chromosome abnormalities have been detected in 92% of patients. Eighteen (14%) patients showed numerical abnormalities only, 50 (38%) patients showed structural abnormalities only, and 53 (40%) patients showed both. The simultaneous trisomies 4, 10 and 17 were observed in 23 (17%) patients. Of the patients with abnormal karyotypes, recurrent structural abnormalities were determined in 103 (78%) cases. t(12;21)(q13;q22) was found in 29 (22%) out of 132 patients, 9p abnormalities in 13 (10%) patients, t(1;19)(q23;p13.3) in 11 (8%) patients, t(9;22)(q34;q11.2) in 11 (8%) patients, and 11q23 abnormalities in 7 (5%) patients. Interestingly, we identified five uncommon translocations such as t(5;12) (q33;p13), t(14;19)(q32;q13.1), t(12;16)(p13;q13), der(1)t(1;12)(p32;p13), and t(5;15)(p15;q11.2). Our study pool is representative of pediatric ALL patients in Korea as it consists of about 20% of patients diagnosed annually in Korea. We believe that the data provided will aid in comparative studies of the treatment outcomes, as well as the type and incidence of chromosomal abnormalities associated with childhood ALL in various Asian nations and Western countries.
Literatur
1.
Zurück zum Zitat Brenner H, Kaatsch P, Burkhardt-Hammer T, Harms DO, Schrappe M, Michaelis J. Long-term survival of children with leukemia achieved by the end of the second millennium. Cancer. 2001;92:1977–83. doi:10.1002/1097-0142(20011001)92:7<1977::AID-CNCR1717>3.0.CO;2-W.CrossRefPubMed Brenner H, Kaatsch P, Burkhardt-Hammer T, Harms DO, Schrappe M, Michaelis J. Long-term survival of children with leukemia achieved by the end of the second millennium. Cancer. 2001;92:1977–83. doi:10.1002/1097-0142(20011001)92:7<1977::AID-CNCR1717>3.0.CO;2-W.CrossRefPubMed
2.
Zurück zum Zitat Moricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dordelmann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111:4477–89. doi:10.1182/blood-2007-09-112920.CrossRefPubMed Moricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dordelmann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111:4477–89. doi:10.​1182/​blood-2007-09-112920.CrossRefPubMed
4.
Zurück zum Zitat Chessells JM, Swansbury GJ, Reeves B, Bailey CC, Richards SM. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol. 1997;99:93–100. doi:10.1046/j.1365-2141.1997.3493163.x.CrossRef Chessells JM, Swansbury GJ, Reeves B, Bailey CC, Richards SM. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol. 1997;99:93–100. doi:10.​1046/​j.​1365-2141.​1997.​3493163.​x.CrossRef
7.
Zurück zum Zitat Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 1993;81:2237–51.PubMed Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 1993;81:2237–51.PubMed
11.
12.
Zurück zum Zitat Nordgren A, Heyman M, Sahlen S, Schoumans J, Soderhall S, Nordenskjold M, et al. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases. Eur J Haematol. 2002;68:31–41. doi:10.1034/j.1600-0609.2002.00547.x.CrossRefPubMed Nordgren A, Heyman M, Sahlen S, Schoumans J, Soderhall S, Nordenskjold M, et al. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases. Eur J Haematol. 2002;68:31–41. doi:10.​1034/​j.​1600-0609.​2002.​00547.​x.CrossRefPubMed
13.
Zurück zum Zitat Woo HY, Kim DW, Park H, Seong KW, Koo HH, Kim SH. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia. J Korean Med Sci. 2005;20:36–41.CrossRefPubMedPubMedCentral Woo HY, Kim DW, Park H, Seong KW, Koo HH, Kim SH. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia. J Korean Med Sci. 2005;20:36–41.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Brunning RD, Borowitz M, Matutes E, Head D, Flandrin G, Swerdlow SH, et al. Precursor B-cell and T-cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman J, editors. World health organization classification of tumours pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 109–18. Brunning RD, Borowitz M, Matutes E, Head D, Flandrin G, Swerdlow SH, et al. Precursor B-cell and T-cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman J, editors. World health organization classification of tumours pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 109–18.
15.
16.
Zurück zum Zitat ISCN. In: Shaffer LG, Tommerup N, editors. An International System for Human Cytogenetic Nomenclature. Basel: S. Karger; 2005. ISCN. In: Shaffer LG, Tommerup N, editors. An International System for Human Cytogenetic Nomenclature. Basel: S. Karger; 2005.
19.
Zurück zum Zitat Li CK, Chik KW, Chan GC, Yuen HL, Lee AC, Shing MM, et al. Treatment of acute lymphoblastic leukemia in Hong Kong children: HKALL 93 study. Hematol Oncol. 2003;21:1–9. doi:10.1002/hon.698.CrossRefPubMed Li CK, Chik KW, Chan GC, Yuen HL, Lee AC, Shing MM, et al. Treatment of acute lymphoblastic leukemia in Hong Kong children: HKALL 93 study. Hematol Oncol. 2003;21:1–9. doi:10.​1002/​hon.​698.CrossRefPubMed
20.
22.
Zurück zum Zitat Sutcliffe MJ, Shuster JJ, Sather HN, Camitta BM, Pullen J, Schultz KR, et al. High concordance from independent studies by the Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children’s Oncology Group (COG) initiative. Leukemia. 2005;19:734–40. doi:10.1038/sj.leu.2403673.CrossRefPubMed Sutcliffe MJ, Shuster JJ, Sather HN, Camitta BM, Pullen J, Schultz KR, et al. High concordance from independent studies by the Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children’s Oncology Group (COG) initiative. Leukemia. 2005;19:734–40. doi:10.​1038/​sj.​leu.​2403673.CrossRefPubMed
23.
Zurück zum Zitat Nordgren A, Farnebo F, Johansson B, Holmgren G, Forestier E, Larsson C, et al. Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping. Eur J Haematol. 2001;66:297–304. doi:10.1034/j.1600-0609.2001.066005297.x.CrossRefPubMed Nordgren A, Farnebo F, Johansson B, Holmgren G, Forestier E, Larsson C, et al. Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping. Eur J Haematol. 2001;66:297–304. doi:10.​1034/​j.​1600-0609.​2001.​066005297.​x.CrossRefPubMed
24.
Zurück zum Zitat Heerema NA, Nachman JB, Sather HN, Sensel MG, Lee MK, Hutchinson R, et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children’s cancer group. Blood. 1999;94:4036–45.PubMed Heerema NA, Nachman JB, Sather HN, Sensel MG, Lee MK, Hutchinson R, et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children’s cancer group. Blood. 1999;94:4036–45.PubMed
25.
Zurück zum Zitat Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Műnster Study Group. Blood. 1997;90:571–7.PubMed Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Műnster Study Group. Blood. 1997;90:571–7.PubMed
28.
Zurück zum Zitat Park KU, She CJ, Shin HY, Ahn HS, Kim CJ, Cho BK, et al. Low incidence of TEL/AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridization. Cancer Genet Cytogenet. 2001;126:73–7. doi:10.1016/S0165-4608(00)00374-5.CrossRefPubMed Park KU, She CJ, Shin HY, Ahn HS, Kim CJ, Cho BK, et al. Low incidence of TEL/AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridization. Cancer Genet Cytogenet. 2001;126:73–7. doi:10.​1016/​S0165-4608(00)00374-5.CrossRefPubMed
29.
Zurück zum Zitat Heerema NA, Sather HN, Sensel MG, Liu-Mares W, Lange BJ, Bostrom BC, et al. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood. 1999;94:1537–44.PubMed Heerema NA, Sather HN, Sensel MG, Liu-Mares W, Lange BJ, Bostrom BC, et al. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood. 1999;94:1537–44.PubMed
30.
Zurück zum Zitat Okuda T, Shurtleff SA, Valentine MB, Raimondi SC, Head DR, Behm F, et al. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood. 1995;85:2321–30.PubMed Okuda T, Shurtleff SA, Valentine MB, Raimondi SC, Head DR, Behm F, et al. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood. 1995;85:2321–30.PubMed
31.
Zurück zum Zitat Pui CH, Behm FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC, et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol. 1994;12:909–15.CrossRefPubMed Pui CH, Behm FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC, et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol. 1994;12:909–15.CrossRefPubMed
32.
Zurück zum Zitat Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood. 1996;87:2870–7.PubMed Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood. 1996;87:2870–7.PubMed
33.
34.
Zurück zum Zitat Schneider NR, Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ, et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood. 2000;96:2543–9.PubMed Schneider NR, Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ, et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood. 2000;96:2543–9.PubMed
35.
Zurück zum Zitat Robinson HM, Taylor KE, Jalali GR, Cheung KL, Harrison CJ, Moorman AV. t(14;19)(q32;q13): A recurrent translocation in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2004;39:88–92. doi:10.1002/gcc.10299.CrossRefPubMed Robinson HM, Taylor KE, Jalali GR, Cheung KL, Harrison CJ, Moorman AV. t(14;19)(q32;q13): A recurrent translocation in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2004;39:88–92. doi:10.​1002/​gcc.​10299.CrossRefPubMed
36.
Zurück zum Zitat Heerema NA, Arthur DC, Sather H, Albo V, Feusner J, Lange BJ, et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Children’s Cancer Group. Blood. 1994;83:2274–84.PubMed Heerema NA, Arthur DC, Sather H, Albo V, Feusner J, Lange BJ, et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Children’s Cancer Group. Blood. 1994;83:2274–84.PubMed
37.
Zurück zum Zitat Wlodarska I, Aventin A, Ingles-Esteve J, Falzetti D, Criel A, Cassiman JJ, et al. A new subtype of pre-B acute lymphoblastic leukemia with t(5;12)(q31q33;p12), molecularly and cytogenetically distinct from t(5;12) in chronic myelomonocytic leukemia. Blood. 1997;89:1716–22.PubMed Wlodarska I, Aventin A, Ingles-Esteve J, Falzetti D, Criel A, Cassiman JJ, et al. A new subtype of pre-B acute lymphoblastic leukemia with t(5;12)(q31q33;p12), molecularly and cytogenetically distinct from t(5;12) in chronic myelomonocytic leukemia. Blood. 1997;89:1716–22.PubMed
Metadaten
Titel
Cytogenetic analysis in childhood acute lymphoblastic leukemia: experience at a single institution in Korea
verfasst von
Young Joo Kwon
Jae Wook Lee
Myung Shin Kim
Pil Sang Jang
Nak Gyun Chung
Dae Chul Jeong
Yong Goo Kim
Kyung Ja Han
Soon Ju Lee
Bin Cho
Hack Ki Kim
Publikationsdatum
01.03.2009
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 2/2009
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-008-0231-z

Weitere Artikel der Ausgabe 2/2009

International Journal of Hematology 2/2009 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.